Endovascular repair of thoracic aortic disease: Overview of current devices and clinical results

Peter H. Lin, Hosam Farouk El Sayed, Panagiotis Kougias, Wei Zhou, Scott A. LeMaire, Joseph S. Coselli

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Endovascular repair of thoracic aortic aneurysm has become an important treatment modality in patients who are at increased risk for open surgical repair. Since the US Food and Drug Administration (FDA) approved the clinical application of this technology in the thoracic aorta in 2005, there has been a rapid growth in this treatment modality as numerous endovascular devices have been introduced in the application of thoracic aortic pathology. Although thoracic aortic aneurysm is the only FDA-approved treatment indication for endovascular repair, this technology may lead to a broader clinical applicability in other thoracic pathologies. This article reviews the current endovascular devices designed for the treatment of thoracic aortic pathology. These devices are described, and the current clinical results are discussed.

Original languageEnglish (US)
Pages (from-to)179-190
Number of pages12
Issue number4
StatePublished - Jul 2007


  • Endovascular repair
  • Endovascular stent graft
  • Thoracic aortic aneurysm
  • Thoracic aortic dissection

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Surgery


Dive into the research topics of 'Endovascular repair of thoracic aortic disease: Overview of current devices and clinical results'. Together they form a unique fingerprint.

Cite this